Dr. Marlena Fejzo, HER Research Adviser and Board of Directors, was invited to speak at February’s Keystone Conference on Maternal-Fetal Crosstalk in Santa Fe, NM. Dr. Fejzo presented “Evidence the placenta and appetite hormone GDF15 causes nausea and vomiting of pregnancy” and met with experts on maternal/fetal health from around the world.
Read More
Be a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!
Read More
The HER Foundation has accomplished a lot in 2022! We are thankful for the support of our donors and community and want to share the highlights that made this HER’s best year yet! This is what 22 years of Helping Generations survive Hyperemesis Gravidarum (HG) looks like.
Read More
The HER Foundation educated me on the website and social media, and I used the HG Care app. When I was scared to take Zofran, they sent me the lastest research. HER understands, and I didn’t feel alone. One day, they will find a cure.
Read More
What is the cause of hyperemesis gravidarum? Dr. Fejzo presented our team’s results from the largest ever genetic study of HG (7,197 HG cases and 178,953 controls) at the American Society of Human Genetics annual conference in Los Angeles on October 26, 2022.
Read More
Dr. Marlena Fejzo, geneticist and HER’s Research Advisor and member of the Board of Directors, was featured in the Inverse article, “When morning sickness kills: doctors have dismissed hyperemesis gravidarum for decades, but new research could undo this harmful legacy.”
Read More
The HER Foundation’s breakthrough psychosocial study shows that Hyperemesis Gravidarum (HG) is not self limiting and has societal implications.
Read More
We put together this list of highlights from 2021! These are some of the people, the work, and the campaigns that made this HER’s best year yet! We are making Hyperemesis Gravidarum (HG) progress!
Read More
HER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.
Read More